Clinical trial

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

NCT00235937

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Anastrozole and goserelin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-12-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Anastrozole and goserelinDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

ToulouseFrance1 RennesFrance1 CaenFrance1 RouenFrance1 AngersFrance1 Saint-HerblainFrance1 PoitiersFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00235937 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.